Boston, United States
Foundation Medicine, founded in 2010, is a pioneering company in precision medicine, based in the United States. Their slogan, "A precision medicine company transforming lives in cancer and beyond," accurately reflects their mission to provide high-quality diagnostic solutions primarily in the field of oncology. The company aims to enhance patient care from diagnosis through treatment and monitoring by integrating real-world data and AI-powered tools.
Their diagnostic capabilities contribute to the advancement of personalized therapies, thereby improving patient outcomes. Though their last investment was an acquisition on 01 January 2015, Foundation Medicine continues to leverage its expertise and vast dataset to persistently innovate within the precision medicine space. This focus on transforming patient care through personalized medical solutions positions them as an attractive prospect for investors interested in the healthcare sector.
Metamark Genetics